This content is from: European Union
Harmonization due for pre-expiry trials in Europe
The scope of the experimental use exemption is a vital issue for both research-based and generic pharmaceutical companies. Ina Schreiber and Cyra Nargolwalla of Cabinet Plasseraud examine attempts to harmonize the law in Europe, and compare practice in France, Germany and the UK
To access our in-house intelligence please request a trial here.
Read this article – and more – for a one-week period.
REQUEST ACCESSAre you already an Managing IP subscriber? Login here